Form 4: Editas Medicine EVP, CHIEF MEDICAL OFFICER Baisong Mei Sells Shares to Cover Tax Obligations

Baisong Mei, EVP, CHIEF MEDICAL OFFICER of Editas Medicine, Inc., sold 6,619 shares of common stock on July 19, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On July 19, 2024, Baisong Mei, the EVP, CHIEF MEDICAL OFFICER of Editas Medicine, Inc., sold 6,619 shares of common stock.
• The sale was executed at a weighted average price of $5.2056 per share.
• The total shares beneficially owned following the transaction is 134,413.
• The sale was conducted under a pre-arranged automatic sales plan adopted on June 14, 2022, to cover tax obligations from vesting restricted stock units on July 18, 2024.
• The transaction was not a discretionary trade.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't indicate a change in the executive's outlook on the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who sell shares to cover tax obligations related to vesting equity awards. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates